.

News

Vesalius News

01/24/2023
Memo Therapeutics: Positive Phase I Data
read more
12/14/2022
CatalYm: Visugromab Development
read more
11/22/2022
CatalYm: EUR 50 Million Financing
read more
.

xxnoxx_zaehler